Evidence map›Paper›PMID 38724833›Full record

ReviewDiscover nano2024

From nature to nanomedicine: bioengineered metallic nanoparticles bridge the gap for medical applications.

Jitendra Patel, G Shiva Kumar, Harekrishna Roy, Balaji Maddiboyina, Stefano Leporatti, Raghvendra A Bohara

Abstract readReview
In one paragraph

Review in Discover nano, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Phytogenic Silver Nanoparticles Derived fromBioengineering (Basel, Switzerland) · 2025
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jitendra PatelGitam School of Pharmacy, GITAM (Deemed to be University), Hyderabad Campus, Rudraram, Sangareddy, Hyderabad, TS, 502329, India.
G Shiva KumarGitam School of Pharmacy, GITAM (Deemed to be University), Hyderabad Campus, Rudraram, Sangareddy, Hyderabad, TS, 502329, India.
Harekrishna RoyDepartment of Pharmaceutics, Nirmala College of Pharmacy, Mangalagiri, Guntur, Andhra Pradesh, 522503, India. hareroy@gmail.com.
Balaji MaddiboyinaDepartment of Medical and Scientific Communications, Scientific Writing Services, Freyr Global Regulatory Solutions & Services, Phoenix SEZ, Hitech City, Gachibowli, Hyderabad, 500081, India. mbalaji113@gmail.com.
Stefano LeporattiCNR Nanotec-Istituto Di Nanotecnologia, C\O Campus EcotekneVia Monteroni, 3100, Lecce, Italy.
Raghvendra A BoharaD.Y. Patil Education Society (Deemed to be University), Kolhapur, MS, India. Raghvendrabohara@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The escalating global challenge of antimicrobial resistance demands innovative approaches. This review delves into the current status and future prospects of bioengineered metallic nanoparticles derived from natural sources as potent antimicrobial agents. The unique attributes of metallic nanoparticles and the abundance of natural resources have sparked a burgeoning field of research in combating microbial infections. A systematic review of the literature was conducted, encompassing a wide range of studies investigating the synthesis, characterization, and antimicrobial mechanisms of bioengineered metallic nanoparticles. Databases such as PubMed, Scopus, Web of Science, ScienceDirect, Springer, Taylor & Francis online and OpenAthen were extensively searched to compile a comprehensive overview of the topic. The synthesis methods, including green and sustainable approaches, were examined, as were the diverse biological sources used in nanoparticle fabrication. The amalgamation of metallic nanoparticles and natural products has yielded promising antimicrobial agents. Their multifaceted mechanisms, including membrane disruption, oxidative stress induction, and enzyme inhibition, render them effective against various pathogens, including drug-resistant strains. Moreover, the potential for targeted drug delivery systems using these nanoparticles has opened new avenues for personalized medicine. Bioengineered metallic nanoparticles derived from natural sources represent a dynamic frontier in the battle against microbial infections. The current status of research underscores their remarkable antimicrobial efficacy and multifaceted mechanisms of action. Future prospects are bright, with opportunities for scalability and cost-effectiveness through sustainable synthesis methods. However, addressing toxicity, regulatory hurdles, and environmental considerations remains crucial. In conclusion, this review highlights the evolving landscape of bioengineered metallic nanoparticles, offering valuable insights into their current status and their potential to revolutionize antimicrobial therapy in the future.

Indexed as

AntimicrobialsGreen synthesisMetallic nanoparticlesNanotechnology

Identifiers

PMID38724833
PMCPMC11082127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.